AF
ORGO icon

Amalgamated Financial’s Organogenesis Holdings ORGO Stock Holding History

Amalgamated Financial’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$232K Buy
+30,462
New +$236K ﹤0.01% 1840

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's ORGO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Organogenesis Holdings (ORGO) in Q1 2022: 30,462 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #1840 among its holdings.

156 funds tracked by Wall St. Rank hold ORGO as of Q1 2022.

  • Amalgamated Financial held 30,462 shares of Organogenesis Holdings worth $232K as of Q1 2022.
  • Organogenesis Holdings was a new Amalgamated Financial position in Q1 2022.
  • Organogenesis Holdings made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1840 holding.
  • 156 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.